MedTrace Logo

High Flow Nasal Cannula After Esophagectomy

NCT05718284 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2023-08-01

No results posted yet for this study

Summary

This study will compare the effect of HFNC versus standard oxygen administration after elective esophagectomy for cancer.

Conditions

  • Esophageal Cancer
  • Postoperative Pulmonary Atelectasis
  • Postoperative Pneumonia
  • Postoperative Pneumothorax
  • Postoperative Infection of Incision
  • Postoperative Acute Myocardial Infarction

Interventions

DEVICE

AIRVO2

APPLICATION OF HIGH FLOW NASAL CANNULA OXYGEN FOR 48 HOURS AFTER ESOPHAGECTOMY

OTHER

STANDARD CARE

APPLICATION OF OXYGEN THROUGH STANDARD CARE FOR 48 HOURS AFTER ESOPHAGECTOMY

Sponsors & Collaborators

  • Cristian Deana

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2024-10-31
Completion
2025-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05718284 on ClinicalTrials.gov